Article
Selection of known Plasmodium falciparum resistance-mediating polymorphisms by artemether-lumefantrine and amodiaquine-sulfadoxine-pyrimethamine but not dihydroartemisinin-piperaquine in Burkina Faso.
Antimicrobial agents and chemotherapy - 1 May 2010
Somé Anyirékun Fabrice, Séré Yves Y, Dokomajilar Christian, Zongo Issaka, Rouamba Noël, Greenhouse Bryan, Ouédraogo Jean-Bosco, Rosenthal Philip J
Abstract excerpt
Artemether-lumefantrine (AL), dihydroartemisinin-piperaquine (DP), and amodiaquine-sulfadoxine-pyrimethamine (AQ-SP) offer excellent antimalarial efficacy but may select for parasite polymorphisms that decrease drug sensitivity. We evaluated the selection of known polymorphisms in genes encoding putative transporters (pfcrt and pfmdr1) and SP targets (pfdhfr and pfdhps) in parasites that caused new infections...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
